Trials / Terminated
TerminatedNCT02479386
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 296 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study seeks to better characterize relationships between visual function and the progression (worsening) of geographic atrophy (GA) due to age-related macular degeneration (AMD). The study is also intended to generate new information on the relationship between genetics and GA progression. This is a global, prospective, multicenter, epidemiologic study enrolling participants with GA secondary to AMD. The study visits are scheduled to occur every 6 months. The anticipated duration of the study is up to 48 months. There is a planned interim analysis around the 2-year time window for the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention was administered in this study. |
Timeline
- Start date
- 2015-06-24
- Primary completion
- 2017-04-14
- Completion
- 2018-01-31
- First posted
- 2015-06-24
- Last updated
- 2019-08-20
Locations
91 sites across 15 countries: United States, Argentina, Australia, Austria, Brazil, Canada, France, Germany, Greece, Hungary, Israel, Italy, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02479386. Inclusion in this directory is not an endorsement.